The Mounjaro price increase explained: what UK patients need to know

What the Eli Lilly list-price change actually shows in practice

Eli Lilly's decision to revise UK list prices from September 2025 was widely reported, and the numbers were stark. At the lower doses, the movement was more modest; at the higher end of the titration schedule, the shift was substantial. As a result, the private market (which had already priced above list to cover clinical and dispensing costs) adjusted accordingly. The typical range now quoted by regulated UK providers sits between roughly £149 and £375 a month, depending on the dose a prescriber deems appropriate for you.

It is worth understanding that Eli Lilly sets a list price, not the price you pay. Every private pharmacy or clinic adds the cost of the consultation, the prescription process, delivery logistics and clinical aftercare. Those services are not optional extras when it comes to a prescription-only medicine, they are part of what makes the supply legal. The reasons behind the UK Mounjaro price increase involve several factors beyond Lilly's pricing alone, and unpicking those helps put any quote you receive in context.

One practical note: because Mounjaro sits in the fridge (most patients keep the pen alongside everyday things like juice or leftovers) it is easy to forget that what you are storing is a carefully regulated medicine, not a supplement you can shop for purely on price. That context matters when you are comparing quotes.

What headline private prices often leave out

A low headline number is rarely the full cost of private Mounjaro treatment. Many providers charge separately for the initial consultation, ongoing prescription reviews, dose-increase assessments, and delivery. Some bundle certain elements and charge for others only when you use them. The result is that a quote of, say, £X per pen can become meaningfully higher once those costs surface.

The categories to check before committing to any provider are: whether the consultation is free or charged per visit; whether clinical review before every repeat is included; whether delivery is free or added per order; and whether aftercare support (the people you contact if you have a question about a side effect or a missed dose) is staffed and accessible. A broader breakdown of how Mounjaro is priced in the UK sets out these variables clearly, because the gap between providers often lives in these charges rather than in the per-pen number itself.

Mounjaro is titrated from a low starting dose upward as the prescriber confirms tolerance and response. Some providers charge differently at different dose levels. If you are starting out and want to know whether the entry-level strength has been caught up in recent pricing shifts, what has happened to the cost of the 2.5 mg starting dose specifically is worth reading before you commit. How the price increase has affected specific dose tiers gives a closer look if you are partway through a titration or comparing options at a particular strength.

Where nume sits in this picture, and why we are not the cheapest

We are not going to win a race to the bottom on price. That is not indifference; it is a deliberate choice about what a clinically safe private service actually costs to run well. At nume, one price covers your free consultation, your prescription, the medicine, and free next-working-day delivery to your door via DPD, tracked, in plain packaging. There are no hidden fees and no subscription pulling money out of your account between orders.

Every repeat order goes through a fresh clinical review by a GPhC-registered Independent Prescriber, not an algorithm. Before we approve a dose increase, we look at evidence of response and tolerance. That process takes time and professional judgment, both of which cost money. It also means patients are not stepping up doses faster than is clinically appropriate, which matters both for safety and for making treatment actually work.

The price increase has made all of this more expensive. We would rather be transparent about that than obscure it with a misleadingly low initial quote. Our current treatment pricing is listed on the weight-loss treatments page, and if you have questions about what is included, our pharmacy team is available seven days a week. There is no obligation involved in asking.

Why the cheapest Mounjaro listing is the wrong place to start

Mounjaro is a Prescription-Only Medicine. It requires an assessment by a qualified prescriber, supplied through a pharmacy registered with the General Pharmaceutical Council. That is not a formality, it is the legal and clinical architecture that makes treatment safe. The MHRA has issued repeated warnings about counterfeit weight-loss pens circulating online and via social media, including fake tirzepatide pens seized from an illicit manufacturing site in the UK in October 2025. You can verify any online pharmacy's registration on the GPhC's public register, ours is listed there under registration number 9012878.

A price far below the current market range, a seller offering Mounjaro without a prescription, or a social-media account advertising discount codes for a POM are all red flags worth taking seriously. The MHRA's Yellow Card scheme accepts reports of suspect sellers alongside suspected side effects. Reporting them helps the regulator act.

The question to ask of any private Mounjaro provider is not "who is cheapest" but "who is safest and most transparent." After a price increase as large as the one that took effect in September 2025, some providers will absorb margin, some will pass costs on, and some (particularly unregulated ones) will sell something that is not what it claims to be. If you are with a provider that has kept its prices steady despite the September changes, it is worth understanding what it means when a UK supplier says there has been no price increase, because the reasons are not always straightforward. The broader access implications of the UK Mounjaro price increase are worth understanding too, because cost has become a genuine barrier for some patients. Speak to our prescribers about your situation, the consultation is free, and there is no pressure to proceed.